Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

An independent privacy official will oversee 23andMe’s proposed sale after Illinois and 26 other states raised concerns about ...

Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking ...

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...

Lawmakers want to know what will be done to make sure consumer genetic testing company 23andMe’s data will stay out of the ...

Regneron stock crashed today following disappointing COPD trials data. Here's what makes REGN shares worth buying on the ...

The bipartisan lawsuit was filed on Monday in St. Louis alongside a separate objection to the bankruptcy sale and is being ...

Regeneron is willing to make a new bid for 23andMe's assets, but wants a $10 million breakup fee if Wojcicki’s bid is ...